LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
Bespak – 21.05.2025
Stoelzle – 15th May 2025

Creating a Fit-for-purpose Supply Chain for the COVID-19 Vaccine

The race is on amongst the international scientific research community to develop a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19. There is also the very real risk of a second wave of Coronavirus infection in countries that have already been badly hit earlier in 2020, as autumn looms. By the end of 2021, the World Health Organisation (WHO) plans to deliver over 2 billion doses of a Coronavirus vaccine internationally to accelerate herd immunity and wipe out the highly infectious virus. Rich Quelch at Origin explains why this ambitious timeline presents a huge challenge for pharmaceutical supply chains and healthcare systems.

 

Scott Pharma – 25.03.2025
SMI – 24/03/2025
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
L.B. Bohle – 08.04.2025